![]() | ![]() |
Formats:
|
||||
Copyright Hindawi Publishing Corporation Anthocyanins and Human Health: An In Vitro Investigative Approach Department of Natural Resources & Environmental Sciences, College of Agricultural Consumer and Environmental Sciences, University of Illinois, Urbana, IL 61801, USA *Mary Ann Lila: Email: imagemal/at/uiuc.edu Received April 2, 2004; Revised May 10, 2004; Accepted May 12, 2004. This article has been cited by other articles in PMC.Abstract Anthocyanin pigments and associated flavonoids have
demonstrated ability to protect against a myriad of human
diseases, yet they have been notoriously difficult to study with
regard to human health. Anthocyanins frequently interact with
other phytochemicals to potentiate biological effects,
thus contributions from individual components are difficult to
decipher. The complex, multicomponent structure of compounds in
a bioactive mixture and the degradation of flavonoids during
harsh extraction procedures obscure the precise assignment of
bioactivity to individual pigments. Extensive metabolic breakdown
after ingestion complicates tracking of anthocyanins to assess
absorption, bioavailability, and accumulation in various organs.
Anthocyanin pigments and other flavonoids that are uniformly,
predictably produced in rigorously controlled plant cell culture
systems can be a great advantage for health and nutrition
research because they are quickly, easily isolated, lack
interferences found in whole fruits, can be elicited to provoke
rapid and prolific accumulation, and are amenable to biolabeling
so that metabolic fate can be investigated after ingestion. ANTHOCYANINS AND BIOMEDICINAL PROPERTIES Anthocyanins are members of the flavonoid group of
phytochemicals, a group predominant in teas, honey, wines,
fruits, vegetables, nuts, olive oil, cocoa, and cereals. The flavonoids,
perhaps the most important single group of phenolics in foods,
comprise a group of over 4000 C15 aromatic plant compounds
with multiple substitution patterns (www.nal.usda.gov/fnic/foodcomp/index.html). The primary players in this group include the anthocyanins (eg, cyanidin,
pelargonidin, petunidin), the flavonols (quercetin, kaempferol),
flavones (luteolin, apigenin), flavanones (myricetin, naringin,
hesperetin, naringenin), flavan-3-ols (catechin, epicatechin,
gallocatechin), and, although sometimes classified separately, the
isoflavones (genistein, daidzein). Phytochemicals in this class
are frequently referred to as bioflavonoids due to their
multifaceted roles in human health maintenance, and anthocyanins in food are typically ingested as
components of complex mixtures of flavonoid components. Daily
intake is estimated from 500 mg to 1 g, but can be
several g/d if an individual is consuming flavonoid supplements
(grape seed extract, ginkgo biloba, or pycnogenol; see, eg,
[1]).The colorful anthocyanins are the most recognized,
visible members of the bioflavonoid phytochemicals. The
free-radical scavenging and antioxidant capacities of anthocyanin
pigments are the most highly publicized of the modus operandi
used by these pigments to intervene with human therapeutic
targets, but, in fact, research clearly suggests that other
mechanisms of action are also responsible for observed health
benefits [2,
3, 4,
5]. Anthocyanin isolates and
anthocyanin-rich mixtures of bioflavonoids may provide protection
from DNA cleavage, estrogenic activity (altering development of
hormone-dependent disease symptoms), enzyme inhibition, boosting
production of cytokines (thus regulating immune responses),
anti-inflammatory activity, lipid peroxidation, decreasing
capillary permeability and fragility, and membrane strengthening
[6,
7, 8,
9, 10].
The chemical structure (position, number,
and types of substitutions) of the individual anthocyanin molecule also has a
bearing on the degree to which anthocyanins exert their bioactive
properties [11, 12] and the structure/function relationships also influence the intracellular localization of the pigments
[7]. The anthocyanin literature includes some controversy
over the relative contributions of glycosylated anthocyanins
versus aglycones in terms of bioavailability and bioactive
potential [7,
13, 14,
15, 16]. Originally, it was assumed
that only aglycones could enter the circulation circuit, however,
absorption and metabolism of anthocyanin glycosides has now been
demonstrated. The nature of the sugar conjugate and the aglycone
are important determinants of anthocyanin absorption and
excretion in both humans and rats [15]. The roles of anthocyanin pigments as medicinal agents have been
well-accepted dogma in folk medicine throughout the world, and, in
fact, these pigments are linked to an amazingly broad-based range
of health benefits. For example, anthocyanins from
Hibiscus sp have historically been used in remedies for liver
disfunction and hypertension; and bilberry (Vaccinium) anthocyanins have an
anecdotal history of use for vision disorders, microbial infections,
diarrhea, and diverse other health disorders [17,
18, 19]. But
while the use of anthocyanins for therapeutic purposes has long been
supported by both anecdotal and epidemiological evidence, it is only
in recent years that some of the specific, measurable pharmacological
properties of isolated anthocyanin pigments have been conclusively verified
by rigorously controlled in vitro, in vivo, or clinical research
trials [4]. In many other cases, the exact roles of the
anthocyanins in human health maintenance versus other
phytochemicals in a complex mixture from a fruit extract or whole
food have not been completely sorted out. In fact, some reports
suggest that anthocyanin activity is potentiated when delivered in
mixtures [20, 21,
22]. For example, visual acuity can be markedly improved through
administration of anthocyanin pigments to animal and human subjects,
and the role of these pigments in enhancing night vision or overall
vision has been particularly well documented [23]. Oral intake
of anthocyanosides from black currants resulted in significantly
improved night vision adaptation in human subjects [24], and
similar benefits were gained after administration of anthocyanins
from bilberries [25]. Three anthocyanins from black currant
stimulated regeneration of rhodopsin (a G-protein-coupled receptor
localized in the retina of the eye), and formation of a regeneration
intermediate was accelerated by cyanidin 3-rutinoside [26].
These studies strongly suggest that enhancement of rhodopsin
regeneration is at least one mechanism by which anthocyanins enhance visual acuity. In both in vitro and in vivo research trials, anthocyanins have
demonstrated marked ability to reduce cancer cell proliferation
and to inhibit tumor formation [27,
28, 29,
30]. The capacity
of anthocyanin pigments to interfere with the process of
carcinogenesis seems to be linked to multiple potential mechanisms of
action including inhibition of cyclooxygenase enzymes and potent
antioxidant potential. Hou et al [20] revealed that anthocyanins
inhibit tumorigenesis by blocking activation of a mitogen-activated
protein kinase pathway. This report provided the first indication of
a molecular basis for why anthocyanins demonstrate anticarcinogenic
properties. In other research, fruit extracts with significant
anthocyanin concentrations proved to be effective against various
stages of carcinogenesis [18,
28, 31,
32], but the individual
role of anthocyanins versus other components was not determined, in
part because the anthocyanins were too easily degraded during
bioassays if separated from stabilizing cofactors such as other
phenolic constituents [33]. The role of anthocyanins in cardiovascular disease protection is
strongly linked to oxidative stress protection. Since endothelial
dysfunction is involved in initiation and development of vascular
disease, four anthocyanins isolated from elderberries were
incorporated into the plasma lemma and cytosol of endothelial
cells to directly examine the protective roles [34]. These
tests demonstrated not only that anthocyanins could be directly
incorporated into endothelial cells, but that significant
oxidative stress protection was the result. Delphinidin, but not
malvidin or cyanidin, provided endothelium-dependent
vasorelaxation in the rat aorta, providing a pharmacological
benefit comparable to red wine polyphenolics [35]. In a rat
model, little influence of feeding purified anthocyanins
(cyanidin 3-O-glucoside) or anthocyanin-rich extracts
from elderberry or blackcurrant could be detected on
cholesterol levels or fatty acid patterns in liver, but the pigments were
capable of sparing vitamin E [36]. Crude anthocyanin
extracts from bilberry have been administered both orally and via
injection to reduce capillary permeability [13]. In other
research related to cardiovascular impairment, the roles of
anthocyanin pigments versus other flavonoids delivered in the
phytochemical extract have not been completely sorted out.
Protection from heart attacks through administration of grape
juice or wine was strongly tied to the ability of the
anthocyanin-rich products to reduce inflammation and enhance
capillary strength and permeability, and to inhibit platelet
formation and enhance nitric oxide (NO) release
[37]. Similarly, delivery of a black currant concentrate
with intense anthocyanin content caused endothelium-dependent
vasorelaxation in rat aorta rings in vitro [38]. The
mechanism of vasorelaxation was attributed to increased levels of
NO production, but the active compounds in the concentrate
were not isolated. When rats were pretreated to create increased
susceptibility to oxidative damage, then fed anthocyanin-rich
extracts, significant reduction in indices of lipid peroxidation
and DNA damage resulted [9]. Ingestion of these extracts,
which contained mixtures of delphinidin, cyanidin, petunidin,
peonidin, and malvidin in the 3-glucopyranoside forms, also
increased plasma antioxidant capacity. Tsuda et al [4] recently provided evidence that anthocyanins
extracted from purple corn, when provided to mice in tandem with
a high-fat diet, effectively inhibited both body weight and adipose
tissue increases. Typical symptoms of hyperglycemia, hyperinsulinemia,
and hyperleptinemia provoked by a high-fat diet did not occur when
mice also ingested isolated anthocyanins. The experiments suggest
that anthocyanins, as a functional food component, can aid in the
prevention of obesity and diabetes. Anthocyanins have been credited with capacity to modulate
cognitive and motor function, to enhance memory, and to have a
role in preventing age-related declines in neural function. Cho
et al [39] reported that administration of isolated
semipurified anthocyanins from purple sweet potato enhanced
cognitive performance as assessed by passive avoidance tests in
ethanol-treated mice, and also effectively inhibited lipid
peroxidation in rat brain tissues. By administering blueberry
extracts with significant anthocyanin content (but not purified
pigments), it was noted that the blueberry-supplemented diets led
to effective reversal of age-related deficits in various neural
and behavioral parameters (memory and motor functions) [40].
Further investigations by this laboratory team demonstrated that
anthocyanins (in particular, cyanidin-3-sambubioside-5-glucoside
and cyanidin-3, 5-diglucoside) were highly bioavailable in
endothelial cells, which was linked to their roles in prevention
of atherosclerosis and neurodegenerative disorders [34,
41]. Anthocyanins exerted multiple protective effects against pleurisy
in a rat model and were capable of attenuating inflammation.
Anthocyanin treatment also downregulated expression of enzymes
involved in inflammation in the lung [10]. The antimicrobial
activity of anthocyanins in general has been well established,
including significant inhibition of aflatoxin biosynthesis [42].
The experimental evidence demonstrating anthocyanin benefits for
diabetes and pancreatic disorders has also accumulated in recent
years, and again the efficacy is attributed to the multiple,
simultaneous biological effects these pigments cause in the body,
including prevention of generation of free radicals, decreased
lipid peroxidation, reduced pancreatic swelling, and decreased
blood sugar concentrations in urine and blood serum [43,
44]. THE ANTHOCYANIN ENIGMA An enigma is defined as anything that perplexes because it is
inexplicable, hidden, or obscure; something that serves as a
puzzle to be solved. The whole realm of anthocyanin consumption
and human health fits into this definition, because several
aspects of anthocyanin's pharmacological roles have remained
elusive to the scientist. In most of the interventions of
anthocyanins in human health, details on the mechanisms of action
for bioactivity, uptake, absorption, bioavailability, whole body
distribution, and tissue localization are still not fully elucidated. There are at least four primary obstacles that have impeded the
formulation, by medical professionals, of robust dietary or
prescriptive guidelines on consumption of anthocyanins. Probably the most complicated piece of the puzzle is that, in
terms of biological activity in the human body, an anthocyanin
pigment is (almost) never acting independently. Typically,
anthocyanins and other flavonoid components, or anthocyanins and
other nonflavonoid phytochemicals, are interacting together in
order to provide full potency. Interactions between phytochemicals
within a plant are a key evolutionary strategy for the host plant.
There are over 4000 flavonoids described, with multiple
substitution patterns and often large complex structures in the
mixtures. Bioflavonoids like anthocyanins occur in mixtures within
edible foods and are ingested in mixtures. Any plant containing
anthocyanins includes a complex phytochemical cocktail. The
anthocyanins and related flavonoids are secondary products typically
produced by plants as defensive, protective, or attractive agents, and
it makes good evolutionary sense for the plant to use a variety of
strategies and multiple fronts of attack to accomplish these
functions, rather than single compounds to which a pathogen or
predator could become resistant. This same multiplicity in bioactive
phytochemical synthesis is also a bonus for animals and humans who
ingest the plant material donors, and benefit from the interaction of
the flavonoids with therapeutic targets. When the interactions between
co-occurring phytochemicals are positive (eg, additive effects or
synergies), they are called potentiating interactions. In other
cases, components in the donor plant can actually inhibit the
bioactivity of the flavonoid compound (eg, pectin interference with
antioxidant capacity in in vitro assays), and in other cases,
concomitant compounds which are not themselves bioactive may work
together with a bioflavonoid to enhance bioavailability or absorption.
Synergy among flavonoids including anthocyanins has been cited as
responsible for antiplatelet activity of red wine and grape juice,
with strong interactions between components of grape skin and grape
seed required to potentiate antiplatelet activity in human and animal
systems [45]. Co-occurring flavonoids working synergistically to
antagonize hydrogen peroxide formation are most effective in
depressing platelet function [46]. Traditional bioprospecting
approaches, which search for single purified plant-derived compounds
as a means of drug discovery, will not capture the full potency of a
plant extract when multiple potentiating interactions are responsible for bioactivity.Another common well-recognized handicap to scientists exploring
the bioactive properties of the flavonoids, and the second part
of the anthocyanin puzzle, is the fact that these phytochemicals
can be of an evanescent nature [33]. The susceptibility of
anthocyanins to oxidation and degradation is one of the concerns
of food processors who wish to maximize the shelf life of products
enhanced with natural pigment colors. In particular, many of the
classic phytochemical methods (including column chromatography), used
to extract from plant tissues and fractionate components out of a
crude extract, can degrade anthocyanins and/or inactivate them during
purification steps. As a result, research that aims to identify
bioactive entities and gauge potencies of extracts can easily fail to
assess the actual sources of biological activity in situ. Strict attention to the ephemeral nature of some flavonoid
constituents in berries (especially during extraction/fractionation
sequences) led to the adaptation of a vacuum chromatography technique
in our laboratory, which was designed to (as much as feasible)
preserve the integrity of the compounds and keep natural mixtures
intact until final separation for purposes of identification
[32,
47]. Using whole individually-quick-frozen berries as a
starting point, fruits are extracted in a Waring blender with 70%
aqueous acetone (~2L solvent kg−1 fruit) then filtered
through cheesecloth. Acetone is removed from the filtrate under
vacuum in a 40°C water bath, and water is then removed
by lyophilization, resulting in a dark purple powder. A portion of
the crude dry extract is then redissolved in water and poured over
a Toyopearl resin polymer column for vacuum chromatography. Vacuum
chromatography on Toyopearl with a series of solvents (water, 50%
MeOH, 100% MeOH, 100% acetone, and 50% acetone)
elutes 5 TP fractions which are then concentrated under vacuum,
and water is removed by lyophilization. Sugars are very quickly and
efficiently removed in the first fraction, which greatly simplifies
the handling and analysis of remaining fractions.Once bioactive fractions are identified, a second, third, and
subsequent rounds of separation are accomplished on silica gel,
also by vacuum, sometimes open column gravity chromatography. At
each step of the procedure, isolated mixtures are compared using
silica gel thin layer chromatography and 2 spray reagents
(vanillin-HCl and dichromate reagent) in order to gauge the
composition and number of components in each fraction. In general,
this fractionation strategy has permitted rapid separation of
relatively large volumes of extract, with less exposure to damaging
and expensive solvents, less exposure to column support materials and
air, minimal losses, and reliable separation of flavonoids. In tandem
with all of the fractionations is a consistent sequence of bioassays
(for multiple stages of carcinogenesis) because the fractionation
scheme is bioactivity-guided. As fractions become more highly
purified, analysis with HPLC, HPLC-MS, and NMR can be used to
conclusively determine the origins of the bioactivity. A third piece of the puzzle is the inducible nature of many of
the bioactive flavonoids including anthocyanins. As is true of a
plethora of secondary plant products, the initial production and
accumulation of phytochemicals is triggered by physical or chemical
microenvironmental triggers, usually a stress factor. The genes
responsible for flavonoid synthesis are highly inducible. As such, a
researcher intent on maximizing production of anthocyanin pigments
must recognize the induction factors and deliberately elicit
production of bioactive flavonoids by providing these stimuli to the
plant material of interest. Elicitation mimics stresses that provoke
secondary product formation in nature, and activates otherwise
dormant biochemical pathways. This triggering of productivity can, of
course, be very difficult to accomplish in a field setting, but can be
accomplished reliably in controlled growth facilities. The final puzzle piece in the “anthocyanin enigma” is the
inability of the scientist or medicinal practitioner to track
metabolic progress of anthocyanins after ingestion, due to the
plethora of metabolic breakdown products that are rapidly produced
in situ. There is substantial current interest in the quest to follow
the transport of bioflavonoids through the body, to determine
absorption and bioavailability, and to see where breakdown products
accumulate and for how long. However, since these phytochemicals are
highly metabolized after consumption of anthocyanin-rich foods or
supplements, metabolic tracking has not been possible. Despite active
research and increasing interest in the realm of natural products and
health maintenance, there is a paucity of information on the
absorption, biodistribution, and metabolism of anthocyanins and
interacting flavonoids. Various plant secondary products have been
implicated in the promotion of good health or the prevention of
disease in humans, but little is known about the way they are
absorbed in the gut, or in which tissues they are deposited throughout
the body. While these issues could be studied if the phytochemicals
were isotopically labeled, generating labeled molecules often is
problematic because many compounds of interest can be synthesized
only in planta at present. IN VITRO ANTHOCYANIN PRODUCTION SYSTEMS The development and optimization of plant cell culture systems
which reliably and predictably synthesize anthocyanins in a controlled
environment has provided a unique and useful model for in-depth
research on anthocyanins, and has helped at least in part to
circumvent the obstacles presented in all four cases of the
“anthocyanin enigma” as described above. Callus and cell suspension
cultures from a wide and diverse range of plant genera have been
cultivated to produce anthocyanin pigments in vitro
[48, 49,
50, 51,
52, 53,
54, 55,
56]. In most of these past
reports, the overall goal of the plant cell culture production system
was to explore an alternative resource for natural plant pigments,
for possible use as food colorants. More recently, some
anthocyanin-producing plant species have been intensively cultured
in vitro in order to harvest the bioactive pigments and related
phytochemicals as medicinally-active compounds [47,
57, 58,
59].
By controlling both the physical and the chemical microenvironment of the
plant cell cultures, anthocyanin production could in many cases be
boosted to higher concentrations than available in the parent plant
in vivo. Some of the most intensively-researched cell culture
production systems used selections from the genus Vitis (grape), where
scaled-up bioreactor-based systems approached semicommercial
productivity [60, 61].
The cell culture systems can be quite
stable, and many have been selected for high anthocyanin yield and
lack of dependence on irradiance. Anthocyanin profiles from cell
cultures do not necessarily mirror the profiles from the parent plant,
and isolation of pigments from the simplified cell culture tissues is
substantially more streamlined than from complex fruit or vegetative
tissues [47, 53,
58]. This simplicity can be a particular
advantage for investigation of the health properties of bioflavonoids including anthocyanins. In most cases, the systems begin with vegetative plant materials
(leaves, petioles, stems) and not fruit tissues. Explants from
in vivo plants are surface-disinfested and introduced into cell
culture to produce rapidly proliferating callus, then cell suspension
cultures, which are eventually induced to produce flavonoids (usually
with a trigger such as light, elevated carbohydrate, changed nitrogen
profile, or elicitation with a fungal extract or other chemical elicitor). Because cell culture anthocyanin production systems are comprised
of simple tissues which can be engineered to reliably and
predictably accumulate pigment, these systems circumvent many of
the obstacles in the anthocyanin enigma. Interactions between
potentiating phytochemicals are still in force in cell culture
systems, but because the tissues are much simpler to extract, the
nature of phytochemical interactions is much easier to sort out
and to quantitatively test. Cell cultures permit rapid and
efficient isolation without many of the interfering compounds
(pectins, excess polysaccharides, enzymes) that can complicate
extraction or bioassay from fruits [18]. Aqueous extracts of
an anthocyanin-producing sweet potato line exhibited
higher potency (antiproliferative and antimutagenic potential) than extract from field-grown crops
[58]. Similarly, when antioxidant capacity of cell cultures
and various fruit extracts were compared side by side in a
galvinoxyl free radical assay, the potency of the cell culture
extract was substantially higher than that of
all fruit extracts, and only grape seed proanthocyanidins
exhibited higher activity [47]. Because these other
substances are not present, the flavonoids are much easier to
isolate without the degradation that can occur rapidly when
isolating slowly from complex, recalcitrant fruit or vegetative tissues. While the flavonoid content of a fruit may comprise only 1% or less
of the total substance, a cell culture can be crafted to accumulate
much higher concentrations of flavonoids, in the range of 20%–30%
by volume. Many flavonoids, in particular, high-molecular weight
proanthocyanidin oligomers or complex anthocyanin isomers, are either
not available commercially or prohibitively expensive. By
producing these phytochemicals in volume in cell cultures, a source
of ready standards is available for testing unknowns [32]. Cell cultures are a superb model system for testing the effects
of elicitation on the inducible bioflavonoid genes, which is a
means of resolving yet another aspect of the anthocyanin enigma.
In fact, elicitation of cell cultures (using chemical or
environmental triggers to production) is a recognized and
efficient means of maximizing anthocyanin pigment towards
commercialization of product recovery [55,
56, 62,
63], and
since the in vitro production environment is rigorously controlled,
investigators have the opportunity to test multiple elicitation
triggers without interference from uncontrolled environmental conditions in field settings. Perhaps the most significant advantage to investigation using in
vitro anthocyanin-accumulating cell cultures is that the cultures
can serve as a vehicle for delivery of isotopic labels (13C or 14C)
to the metabolizing cells while the pigments are being biosynthesized
[59, 64,
65]. By using a radioisotope-labeled source of
compounds, an administered phytochemical can be included in a defined
diet and can be discerned from preexisting, endogenous sources of
the same phytochemical or breakdown product. These large molecules
must be synthesized in planta. In this emerging research area,
radiolabel or isotopic label has been introduced to metabolizing
cell cultures using a carbohydrate source (sucrose or glucose) or a
precursor which is much further along the metabolic pathway to
anthocyanin synthesis, such as phenylalanine. Levels of incorporation
range between 15% and 30%, and levels achieved now allow organ and
neuronal localization of the 14C-labeled compounds and
monitoring using autoradiography and scintillation counting.
Accelerator mass spectrometry (AMS) technology will even permit
monitoring of small levels in human systems. With these innovations,
it is clear that the effective use of cell-culture-produced
anthocyanins can now elucidate previously hidden roles of
anthocyanin pigments in human health and metabolism. References 1. Skibola C, Smith M. Potential health impacts of excessive flavonoid intake. Free Radic Biol Med. 2000;29(3-4):375–383. [PubMed] 2. Tsuda T, Shiga K, Ohshima K, Kawakishi S, Osawa T. Inhibition of lipid peroxidation and the active oxygen
radical scavenging effect of anthocyanin pigments isolated
from Phaseolus vulgaris L. Biochem Pharmacol. 1996;52(7):1033–1039. [PubMed] 3. Tsuda T, Horio F, Osawa T. Cyanidin 3-O-beta-D-glucoside suppresses nitric oxide
production during a zymosan treatment in rats. J Nutr Sci Vitaminol (Tokyo). 2002;48(4):305–310. [PubMed] 4. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color
prevents obesity and ameliorates hyperglycemia in mice. J Nutr. 2003;133(7):2125–2130. [PubMed] 5. Wang S, Jiao H. Scavenging capacity of berry crops on superoxide radicals,
hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem. 2000;48(11):5677–5684. [PubMed] 6. Acquaviva R, Russo A, Galvano F, et al. Cyanidin and cyanidin 3-O-beta-D-glucoside as DNA cleavage
protectors and antioxidants. Cell Biol Toxicol. 2003;19(4):243–252. [PubMed] 7. Lazze M, Pizzala R, Savio M, Stivala L, Prosperi E, Bianchi L. Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth
muscle and hepatoma cells. Mutat Res. 2003;535(1):103–115. [PubMed] 8. Lefevre M, Howard L, Most M, Ju Z, Delany J. Microarray analysis of the effects of grape anthocyanins on hepatic gene
expression in mice. FASEB J. 2004;18:A851. 9. Ramirez-Tortosa C, Andersen O, Gardner P, et al. Anthocyanin-rich extract decreases indices of lipid
peroxidation and DNA damage in vitamin E-depleted rats. Free Radic Biol Med. 2001;31(9):1033–1037. [PubMed] 10. Rossi A, Serraino I, Dugo P, et al. Protective effects of anthocyanins from blackberry in a rat
model of acute lung inflammation. Free Radic Res. 2003;37(8):891–900. [PubMed] 11. Prior R, Cao G, Martin A, et al. Antioxidant capacity as influenced by total phenolic and anthocyanin content,
maturity, and variety of Vaccinium species. J Agric Food Chem. 1998;46(7):2686–2693. 12. Russo A, Acquaviva R, Campisi A, et al. Bioflavonoids as antiradicals, antioxidants and DNA
cleavage protectors. Cell Biol Toxicol. 2000;16(2):91–98. [PubMed] 13. Kong J.M, Chia L.S, Goh N.K, Chia T.F, Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry. 2003;64(5):923–933. [PubMed] 14. Matsumoto H, Nakamura Y, Hirayama M, Yoshiki Y, Okubo K. Antioxidant activity of black currant anthocyanin aglycons
and their glycosides measured by chemiluminescence in a neutral
pH region and in human plasma. J Agric Food Chem. 2002;50(18):5034–5037. [PubMed] 15. McGhie T, Ainge G, Barnett L, Cooney J, Jensen D. Anthocyanin glycosides from berry fruit are absorbed and excreted
unmetabolized by both humans and rats. J Agric Food Chem. 2003;51(16):4539–4548. [PubMed] 16. Miyazawa T, Nakagawa K, Kudo M, Muraishi K, Someya K. Direct intestinal absorption of red fruit anthocyanins,
cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats
and humans. J Agric Food Chem. 1999;47(3):1083–1091. [PubMed] 17. Rice-Evans C, Packer L, editors. NY: Marcel Dekker; 1998. Flavonoids in Health and Disease. 18. Smith M, Marley K, Seigler D, Singletary K, Meline B. Bioactive properties of wild blueberry fruits. J Food Sci. 2000;65:352–356. 19. Wang C, Wang J, Lin W, Chu C, Chou F, Tseng T. Protective effect of Hibiscus anthocyanins against tert-butyl
hydroperoxide-induced hepatic toxicity in rats. Food Chem Toxicol. 2000;38(5):411–416. [PubMed] 20. Hou D.X, Kai K, Li J.J, et al. Anthocyanidins inhibit activator protein 1 activity and
cell transformation: structure-activity relationship and molecular
mechanisms. Carcinogenesis. 2004;25(1):29–36. [PubMed] 21. Liu R. Health benefits of fruit and vegetables are from
additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78(suppl 3):517S–520S. [PubMed] 22. Stintzing F, Stintzing A, Carle R, Frei B, Wrolstad R. Color and antioxidant properties of cyanidin-based anthocyanin pigments. J Agric Food Chem. 2002;50(21):6172–6181. [PubMed] 23. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M, Tsuda T. Orally administered delphinidin 3-rutinoside and cyanidin
3-rutinoside are directly absorbed in rats and humans and appear
in the blood as the intact forms. J Agric Food Chem. 2001;49(3):1546–1551. [PubMed] 24. Nakaishi H, Matsumoto H, Tominaga S, Hirayama M. Effects of black currant anthocyanoside intake on dark adaptation and VDT
work-induced transient refractive alteration in healthy humans. Altern Med Rev. 2000;5(6):553–562. [PubMed] 25. Muth E.R, Laurent J, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast
sensitivity. Altern Med Rev. 2000;5(2):164–173. [PubMed] 26. Matsumoto H, Nakamura Y, Tachibanaki S, Kawamura S, Hirayama M. Stimulatory effect of cyanidin 3-glycosides on the regeneration of rhodopsin. J Agric Food Chem. 2003;51(12):3560–3563. [PubMed] 27. Hou D.X. Potential mechanisms of cancer chemoprevention by anthocyanins. Curr Mol Med. 2003;3(2):149–159. [PubMed] 28. Kang S, Seeram N, Nair M, Bourquin L. Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce
proliferation of human colon cancer cells. Cancer Lett. 2003;194(1):13–19. [PubMed] 29. Koide T, Hashimoto Y, Kamei H, Kojima T, Hasegawa M, Terabe K. Antitumor effect of anthocyanin fractions extracted from
red soybeans and red beans in vitro and in vivo. Cancer Biother Radiopharm. 1997;12(4):277–280. [PubMed] 30. Meiers S, Kemeny M, Weyand U, Gastpar R, von Angerer E, Marko D. The anthocyanidins cyanidin and delphinidin are potent
inhibitors of the epidermal growth-factor receptor. J Agric Food Chem. 2001;49(2):958–962. [PubMed] 31. Bomser J, Madhavi D, Singletary K, Smith M.A. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med. 1996;62(3):212–216. [PubMed] 32. Kandil F, Song L, Pezzuto J, Seigler D, Smith M.A. Isolation of oligomeric proanthocyanidins from flavonoid-producing cell cultures. In Vitro Cell Dev Biol Plant. 2000;36:492–500. 33. Mazza G, Miniati E. Boca Raton, Fla: CRC Press; 1993. Anthocyanins in Fruits, Vegetables, and Grains. 34. Youdim K, Martin A, Joseph J. Incorporation of the elderberry anthocyanins by endothelial cells increases protection against
oxidative stress. Free Radic Biol Med. 2000;29(1):51–60. [PubMed] 35. Andriambeloson E, Magnier C, Haan-Archipoff G, et al. Natural dietary polyphenolic compounds cause
endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998;128(12):2324–2333. [PubMed] 36. Frank J, Kamal-Eldin A, Lundh T, Maatta K, Torronen R, Vessby B. Effects of dietary anthocyanins on tocopherols and lipids in rats. J Agric Food Chem. 2002;50(25):7226–7230. [PubMed] 37. Folts J. Antithrombotic potential of grape juice and red wine
for preventing heart attacks. Pharm Biol. 1998;36(suppl):21–27. 38. Nakamura Y, Matsumoto H, Todoki K. Endothelium-dependent vasorelaxation induced by black currant
concentrate in rat thoracic aorta. Jpn J Pharmacol. 2002;89(1):29–35. [PubMed] 39. Cho J, Kang J, Long P, Jing J, Back Y, Chung K. Antioxidant and memory enhancing effects of purple sweet
potato anthocyanin and Cordyceps mushroom extract. Arch Pharm Res. 2003;26(10):821–825. [PubMed] 40. Joseph J, Shukitt-Hale B, Denisova N, et al. Reversals of age-related declines in neuronal signal transduction,
cognitive, and motor behavioral deficits with blueberry, spinach,
or strawberry dietary supplementation. J Neurosci. 1999;19(18):8114–8121. [PubMed] 41. Youdim K, McDonald J, Kalt W, Joseph J. Potential role of dietary flavonoids in reducing microvascular endothelium
vulnerability to oxidative and inflammatory insults. J Nutr Biochem. 2002;13(5):282–288. [PubMed] 42. Norton R. Inhibition of aflatoxin B(1) biosynthesis in Aspergillus flavus
by anthocyanidins and related flavonoids. J Agric Food Chem. 1999;47(3):1230–1235. [PubMed] 43. Jankowski A, Jankowska B, Niedworok J. The influence of Aronia melanocapra in experimental pancreatitis. Pol Merkuriusz Lek. 2000;8(48):395–398. [PubMed] 44. Jankowski A, Jankowska B, Niedworok J. The effect of anthocyanin dye from grapes on experimental diabetes. Folia Med Cracov. 2000;41(3-4):5–15. [PubMed] 45. Shanmuganayagam D, Beahm M, Osman H, Krueger C, Reed J, Folts J. Grape seed and grape skin extracts elicit a greater
antiplatelet effect when used in combination than when used
individually in dogs and humans. J Nutr. 2002;132(12):3592–3598. [PubMed] 46. Pignatelli P, Pulcinelli F, Celestini A, et al. The flavonoids quercetin and catechin synergistically inhibit
platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr. 2000;72(5):1150–1155. [PubMed] 47. Kandil F, Smith M, Rogers R, et al. Composition of a chemopreventive proanthocyanidin-rich fraction from cranberry fruits responsible for the inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity. J Agric Food Chem. 2002;50(5):1063–1069. [PubMed] 48. Callebaut A, Declere M, Vandermeren K. Ajuga reptans (Bugle). In vitro production of anthocyanins. In: Bajaj Y.P.S, editor. Biotechnology in Agriculture and Forestry 24. Medicinal and Aromatic Plants V. Berlin: Springer-Verlag; 1993. pp. 1–22. 49. Cormier F, Crevier H, Do C. Effects of sucrose concentration on the accumulation of anthocyanins ingrape
(Vitis vinifera L.) cell suspension. Can J Bot. 1990;68:1822–1825. 50. Ilan A, Dougall D. The effect of growth retardants on anthocyanin production
in carrot cell suspension cultures. Plant Cell Rep. 1992;11(5-6):304–309. 51. Kobayashi Y, Akita M, Sakamoto K, et al. Large-scale production of anthocyanin by Aralia cordata
cell suspension cultures. Appl Microbiol Biotechnol. 1993;40(2-3):215–218. 52. Konczak-Islam I, Yoshinaga M, Nakatani M, Terahara N, Yamakawa O. Establishment and characteristics of an anthocyanin-producing
cell line from sweet potato storage root. Plant Cell Rep. 2000;19:472–477. 53. Meyer J, Pépin M.F, Smith M. Anthocyanin production from Vaccinium pahalae: limitations of the physical
microenvironment. J Biotechnol. 2002;93(1):45–57. [PubMed] 54. Mizukami H. Hibiscus sabdariffa L. (Roselle): In vitro culture and the
production of anthocyanins. In: Bajaj Y.P.S, editor. Biotechnology in Agriculture and Forestry 24. Medicinal and Aromatic Plants V. Berlin: Springer-Verlag; 1993. pp. 218–228. 55. Zhong J, Yoshida M, Fujiyama D, Seki T, Yoshida T. Enhancement of anthocyanin production by Perilla frutescens cells in
a stirred bioreactor with internal light irradiation. J Ferment Bioeng. 1993;75(4):299–303. 56. Zubko M, Schmeer K, Gläßgen W, Bayer E, Seitz H. Selection of anthocyanin-accumulating potato (Solanum tuberosum L.) cell lines from calli derived from seedlings germinated from gamma-irradiated seeds. Plant Cell Rep. 1993;12:555–558. 57. Pezet R, Perret C, Jean-Denis J, Tabacchi R, Gindro K, Viret O. Delta-viniferin, a resveratrol dehydrodimer: one of the
major stilbenes synthesized by stressed grapevine leaves. J Agric Food Chem. 2003;51(18):5488–5492. [PubMed] 58. Konczak-Islam I, Yoshimoto M, Hou D, Terahara N, Yamakawa O. Potential chemopreventive properties of anthocyanin-rich aqueous
extracts from in vitro produced tissue of sweetpotato (Ipomoea batatas L.). J Agric Food Chem. 2003;51(20):5916–5922. [PubMed] 59. Yousef G, Seigler D, Grusak M, et al. Biosynthesis and characterization of 14C-enriched flavonoid fractions from
plant cell suspension cultures. J Agric Food Chem. 2004;52(5):1138–1145. [PubMed] 60. Payne G, Bringi V, Prince C, Shuler M. NY: Hanser; 1992. Plant Cell and Tissue Culture in Liquid Systems. 61. Shuler M, Hirasuna T, Prince C, Bringi V. Bioreactor considerations for producing flavors and pigments from
plant tissue culture. In: Schwarzberg H, Rao M, editors. Bioprocess and Food Process Engineering. New York: Marcel-Dekker; 1990. pp. 45–66. 62. Hirner A, Veit S, Seitz H. Regulation of anthocyanin biosynthesis in UV-A-irradiated
cell cultures of carrot and in organs of intact carrot plants. Plant Sci. 2001;161(2):315–322. [PubMed] 63. Mori T, Sakurai M, Sakuta M. Effects of conditioned medium on activities of PAL, CHS,
DAHP synthase (DS-Co and DS-Mn) and anthocyanin production in
suspension cultures of Fragaria ananassa. Plant Sci. 2001;160(2):335–360. 64. Grusak M, Rogers R, Yousef G, Erdman J., Jr, Lila M. An enclosed-chamber labeling system for the safe 14C-enrichment of phytochemicals in plant cell suspension cultures. In Vitro Cell Dev Biol Plant. 2004;40:80–85. 65. Vitrac X, Desmouliere A, Brouillaud B, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive
polyphenol, in mouse tissues after oral administration. Life Sci. 2003;72(20):2219–2233. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||
Free Radic Biol Med. 2000 Aug; 29(3-4):375-83.
[Free Radic Biol Med. 2000]Biochem Pharmacol. 1996 Oct 11; 52(7):1033-9.
[Biochem Pharmacol. 1996]J Nutr Sci Vitaminol (Tokyo). 2002 Aug; 48(4):305-10.
[J Nutr Sci Vitaminol (Tokyo). 2002]J Nutr. 2003 Jul; 133(7):2125-30.
[J Nutr. 2003]J Agric Food Chem. 2000 Nov; 48(11):5677-84.
[J Agric Food Chem. 2000]Cell Biol Toxicol. 2003 Aug; 19(4):243-52.
[Cell Biol Toxicol. 2003]Food Chem Toxicol. 2000 May; 38(5):411-6.
[Food Chem Toxicol. 2000]J Nutr. 2003 Jul; 133(7):2125-30.
[J Nutr. 2003]Carcinogenesis. 2004 Jan; 25(1):29-36.
[Carcinogenesis. 2004]Am J Clin Nutr. 2003 Sep; 78(3 Suppl):517S-520S.
[Am J Clin Nutr. 2003]J Agric Food Chem. 2002 Oct 9; 50(21):6172-81.
[J Agric Food Chem. 2002]J Agric Food Chem. 2001 Mar; 49(3):1546-51.
[J Agric Food Chem. 2001]Altern Med Rev. 2000 Dec; 5(6):553-62.
[Altern Med Rev. 2000]Altern Med Rev. 2000 Apr; 5(2):164-73.
[Altern Med Rev. 2000]J Agric Food Chem. 2003 Jun 4; 51(12):3560-3.
[J Agric Food Chem. 2003]Curr Mol Med. 2003 Mar; 3(2):149-59.
[Curr Mol Med. 2003]Cancer Lett. 2003 May 8; 194(1):13-9.
[Cancer Lett. 2003]Cancer Biother Radiopharm. 1997 Aug; 12(4):277-80.
[Cancer Biother Radiopharm. 1997]J Agric Food Chem. 2001 Feb; 49(2):958-62.
[J Agric Food Chem. 2001]Carcinogenesis. 2004 Jan; 25(1):29-36.
[Carcinogenesis. 2004]Free Radic Biol Med. 2000 Jul 1; 29(1):51-60.
[Free Radic Biol Med. 2000]J Nutr. 1998 Dec; 128(12):2324-33.
[J Nutr. 1998]J Agric Food Chem. 2002 Dec 4; 50(25):7226-30.
[J Agric Food Chem. 2002]Phytochemistry. 2003 Nov; 64(5):923-33.
[Phytochemistry. 2003]Jpn J Pharmacol. 2002 May; 89(1):29-35.
[Jpn J Pharmacol. 2002]J Nutr. 2003 Jul; 133(7):2125-30.
[J Nutr. 2003]Arch Pharm Res. 2003 Oct; 26(10):821-5.
[Arch Pharm Res. 2003]J Neurosci. 1999 Sep 15; 19(18):8114-21.
[J Neurosci. 1999]Free Radic Biol Med. 2000 Jul 1; 29(1):51-60.
[Free Radic Biol Med. 2000]J Nutr Biochem. 2002 May; 13(5):282-288.
[J Nutr Biochem. 2002]Free Radic Res. 2003 Aug; 37(8):891-900.
[Free Radic Res. 2003]J Agric Food Chem. 1999 Mar; 47(3):1230-5.
[J Agric Food Chem. 1999]Pol Merkur Lekarski. 2000 Jun; 8(48):395-8.
[Pol Merkur Lekarski. 2000]Folia Med Cracov. 2000; 41(3-4):5-15.
[Folia Med Cracov. 2000]J Nutr. 2002 Dec; 132(12):3592-8.
[J Nutr. 2002]Am J Clin Nutr. 2000 Nov; 72(5):1150-5.
[Am J Clin Nutr. 2000]J Agric Food Chem. 2002 Feb 27; 50(5):1063-9.
[J Agric Food Chem. 2002]J Biotechnol. 2002 Jan 31; 93(1):45-57.
[J Biotechnol. 2002]J Agric Food Chem. 2002 Feb 27; 50(5):1063-9.
[J Agric Food Chem. 2002]J Agric Food Chem. 2003 Aug 27; 51(18):5488-92.
[J Agric Food Chem. 2003]J Agric Food Chem. 2003 Sep 24; 51(20):5916-22.
[J Agric Food Chem. 2003]J Agric Food Chem. 2004 Mar 10; 52(5):1138-45.
[J Agric Food Chem. 2004]J Agric Food Chem. 2003 Sep 24; 51(20):5916-22.
[J Agric Food Chem. 2003]J Agric Food Chem. 2002 Feb 27; 50(5):1063-9.
[J Agric Food Chem. 2002]Plant Sci. 2001 Jul; 161(2):315-322.
[Plant Sci. 2001]J Agric Food Chem. 2004 Mar 10; 52(5):1138-45.
[J Agric Food Chem. 2004]Life Sci. 2003 Apr 4; 72(20):2219-33.
[Life Sci. 2003]